Table 1 Data of stage IB1 to IIA2 patients before and after matching
Variables | Unmatched | Matched | ||||
|---|---|---|---|---|---|---|
R-CT (n = 582) | RH (n = 4308) | p-value | R-CT (n = 535) | RH (n = 535) | p-value | |
Age (years) | 55.4 ± 11.2 | 48.0 ± 9.7 | 0.000 | 54.3 ± 10.1 | 54.3 ± 10.0 | 1.000 |
FIGO stage | 0.000 | 1.000 | ||||
IB1 | 84 (14.4%) | 2770 (64.3%) | 81 (15.1%) | 81 (15.1%) | ||
IB2 | 60 (10.3%) | 322 (7.5%) | 56 (10.5%) | 56 (10.5%) | ||
IIA1 | 237 (40.7%) | 985 (22.9%) | 219 (40.9%) | 219 (40.9%) | ||
IIA2 | 201 (34.6%) | 231 (5.3%) | 179 (33.5%) | 179 (33.5%) | ||
Histological type | 0.000 | 1.000 | ||||
SCC | 549 (94.3%) | 3863 (89.7%) | 516 (96.4%) | 516 (96.4%) | ||
AC | 20 (3.5%) | 341 (7.9%) | 11 (2.1%) | 11 (2.1%) | ||
SAC | 13 (2.2%) | 104 (2.4%) | 8 (1.5%) | 8 (1.5%) | ||
Tumour size | 0.000 | 1.000 | ||||
> 4 cm | 292 (50.2%) | 3404 (79.0%) | 268 (50.1%) | 268 (50.1%) | ||
≤ 4 cm | 290 (49.8%) | 904 (21.0%) | 267 (49.9%) | 267 (49.9%) | ||